Akin Oyedele
Mar. 26, 2015, 8:22 AM
1,134
Wikimedia CommonsSome investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains […]
View photo.(Wikimedia Commons)Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for the […]
By Dow Jones Business News, March 25, 2015, 02:10:00 PM EDTAAABy Anora Mahmudova and Barbara Kollmeyer, MarketWatchDurable-goods orders drop in February; Kraft, Kofex up on M&A newsNEW YORK (MarketWatch) — U.S. stocks fell on Wednesday, declining for the third straight session, as a selloff in technology and biotech stocks pushed indexes lower.The S&P 500 (SPX) lost 19.06 points, or 0.9%, […]
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]
Akin Oyedele
Mar. 23, 2015, 2:21 PM
1,194
Biotech stocks are on fire.That’s given some analysts flashbacks of 2000, when tech valuations were red hot, but it didn’t end well because they crashed.Michael Batnick over at The Irrelevant Investor posted this chart Monday that compares the rally in tech stocks then to biotechs in recent years.He describes the biotech rally:”In the 168 weeks since […]
ShutterstockNEW YORK (MarketWatch)—Biotech stocks slumped Monday, with the largest biotech ETF down about 1.7% and on track to snap an eight-session winning streak.The slide comes as some market watchers warn that biotech shares have enjoyed a great run-up and could be due for a drop.“Biotech must be slaughtered” is how a post over at the iBankCoin blog puts it.How low […]
I’m baaaack…Yep – back in the saddle after roughing it in the desert for a week. I fended off mountain lion attacks…lost a few bucks betting on March Madness during a detour to Vegas…and meditated on the markets while staring up at the stars.Stocks stabilized in my absence after wandering lower during that pesky early-March pullback. The major averages aren’t […]
Share on StockTwitsEmbedIt’s easy to grin when your ships comes in and you have the stock market beat…but a man worthwhile is a man that can smile, when his shorts are too tight in the seat..
Ted Knight, Caddy shack
I miss Ted Knight. I know this quote by heart and I learned it before I cared about stocks and markets. I […]
Welcome to Friday. Here are three things to keep an eye on during the trading day.Two of today’s three are animated by near-opposite human cravings, but both have been crucial drivers of this bull market: biotech stocks and REITs.Number 1:Biotechs are all about a hoped-for future, the promised huge payoff from smarts and risk-taking, magic molecules to extend lives and […]
By Ben LevisohnBiotech stocks like Gilead Sciences (GILD) and Amgen (AMGN) have been a great place to be for investors. Now, the approval of the first biosimilar in the U.S. is raising concerns that biotech profits will decline–and causing their stocks to tumble. Citigroup’s Andrew Baum and team explain why:
Bloomberg News
Approval of Sandoz’s Zarxio, with full extrapolation across indications and lack […]
